257 related articles for article (PubMed ID: 33772980)
1. Potent anti-mycobacterial and immunomodulatory activity of some bioactive molecules of Indian ethnomedicinal plants that have the potential to enter in TB management.
Sarangi A; Das BS; Patnaik G; Sarkar S; Debnath M; Mohan M; Bhattacharya D
J Appl Microbiol; 2021 Oct; 131(4):1578-1599. PubMed ID: 33772980
[TBL] [Abstract][Full Text] [Related]
2. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
3. Recent updates on drug resistance in Mycobacterium tuberculosis.
Singh R; Dwivedi SP; Gaharwar US; Meena R; Rajamani P; Prasad T
J Appl Microbiol; 2020 Jun; 128(6):1547-1567. PubMed ID: 31595643
[TBL] [Abstract][Full Text] [Related]
4. Anti-mycobacterial activity of some medicinal plants used traditionally by tribes from Madhya Pradesh, India for treating tuberculosis related symptoms.
Gupta VK; Kaushik A; Chauhan DS; Ahirwar RK; Sharma S; Bisht D
J Ethnopharmacol; 2018 Dec; 227():113-120. PubMed ID: 30172059
[TBL] [Abstract][Full Text] [Related]
5. Editorial: Current status and perspective on drug targets in tubercle bacilli and drug design of antituberculous agents based on structure-activity relationship.
Tomioka H
Curr Pharm Des; 2014; 20(27):4305-6. PubMed ID: 24245755
[TBL] [Abstract][Full Text] [Related]
6. [Prospects for development of new antituberculous drugs].
Tomioka H
Kekkaku; 2002 Aug; 77(8):573-84. PubMed ID: 12235850
[TBL] [Abstract][Full Text] [Related]
7. New perspectives on the treatment of mycobacterial infections using antibiotics.
He Y; Fan A; Han M; Zhang Y; Tong Y; Zheng G; Zhu S
Appl Microbiol Biotechnol; 2020 May; 104(10):4197-4209. PubMed ID: 32185432
[TBL] [Abstract][Full Text] [Related]
8. Allicin enhances antimicrobial activity of macrophages during Mycobacterium tuberculosis infection.
Dwivedi VP; Bhattacharya D; Singh M; Bhaskar A; Kumar S; Fatima S; Sobia P; Kaer LV; Das G
J Ethnopharmacol; 2019 Oct; 243():111634. PubMed ID: 30537531
[TBL] [Abstract][Full Text] [Related]
9. [Frontier of mycobacterium research--host vs. mycobacterium].
Okada M; Shirakawa T
Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
[TBL] [Abstract][Full Text] [Related]
10. A review of recent advances in anti-tubercular drug development.
Umumararungu T; Mukazayire MJ; Mpenda M; Mukanyangezi MF; Nkuranga JB; Mukiza J; Olawode EO
Indian J Tuberc; 2020 Oct; 67(4):539-559. PubMed ID: 33077057
[TBL] [Abstract][Full Text] [Related]
11. Isoniazid derivatives and their anti-tubercular activity.
Hu YQ; Zhang S; Zhao F; Gao C; Feng LS; Lv ZS; Xu Z; Wu X
Eur J Med Chem; 2017 Jun; 133():255-267. PubMed ID: 28390957
[TBL] [Abstract][Full Text] [Related]
12. Tuberculosis: Pathogenesis, Current Treatment Regimens and New Drug Targets.
Alsayed SSR; Gunosewoyo H
Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982277
[No Abstract] [Full Text] [Related]
13. Neoteric advancement in TB drugs and an overview on the anti-tubercular role of peptides through computational approaches.
Khusro A; Aarti C; Barbabosa-Pliego A; Salem AZM
Microb Pathog; 2018 Jan; 114():80-89. PubMed ID: 29174699
[TBL] [Abstract][Full Text] [Related]
14. [Recent progress in mycobacteriology].
Okada M; Kobayashi K
Kekkaku; 2007 Oct; 82(10):783-99. PubMed ID: 18018602
[TBL] [Abstract][Full Text] [Related]
15. Understanding the Reciprocal Interplay Between Antibiotics and Host Immune System: How Can We Improve the Anti-Mycobacterial Activity of Current Drugs to Better Control Tuberculosis?
Park HE; Lee W; Shin MK; Shin SJ
Front Immunol; 2021; 12():703060. PubMed ID: 34262571
[TBL] [Abstract][Full Text] [Related]
16. Lipolytic enzymes inhibitors: A new way for antibacterial drugs discovery.
Cavalier JF; Spilling CD; Durand T; Camoin L; Canaan S
Eur J Med Chem; 2021 Jan; 209():112908. PubMed ID: 33071055
[TBL] [Abstract][Full Text] [Related]
17. The phytochemical bergenin as an adjunct immunotherapy for tuberculosis in mice.
Kumar S; Sharma C; Kaushik SR; Kulshreshtha A; Chaturvedi S; Nanda RK; Bhaskar A; Chattopadhyay D; Das G; Dwivedi VP
J Biol Chem; 2019 May; 294(21):8555-8563. PubMed ID: 30975902
[TBL] [Abstract][Full Text] [Related]
18. Natural products and their analogues acting against Mycobacterium tuberculosis: A recent update.
Kumar G; C A
Drug Dev Res; 2023 Aug; 84(5):779-804. PubMed ID: 37086027
[TBL] [Abstract][Full Text] [Related]
19. Host Directed Therapies for Tuberculosis: Futures Strategies for an Ancient Disease.
Palucci I; Delogu G
Chemotherapy; 2018; 63(3):172-180. PubMed ID: 30032143
[TBL] [Abstract][Full Text] [Related]
20. Harnessing Biological Insight to Accelerate Tuberculosis Drug Discovery.
de Wet TJ; Warner DF; Mizrahi V
Acc Chem Res; 2019 Aug; 52(8):2340-2348. PubMed ID: 31361123
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
